alogliptin benz/metformin HCl

12.5-1000, 12.5-500MG — Tablet

DIABETES NON-INSULIN

Also known as: KAZANO ALOGLIPTIN-METFORMIN

Coverage by Insurer

Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Source: PDF  ·  Formulary date: Oct 1, 2026  ·  Checked: 8 hours, 30 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
NC Medicaid Preferred Drug List 2026
via alogliptin-metformin
Non-Preferred — — — None
NC Medicaid Preferred Drug List 2026
via Kazano
Non-Preferred — — — None
Source: Excel (XLSX)  ·  Formulary date: Oct 29, 2026  ·  Checked: 8 hours, 30 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
TRICARE Uniform Formulary 2026
via alogliptin-metformin
Tier 3 - Non-Formulary — ✓ — ST Step therapy: 9DPP-4 INHIBITORS SECONDARY RULE- SEL DPP-4 INHIBITORS REQ PA W/O SELECT ANTI-HYPREGLYCEMIC
TRICARE Uniform Formulary 2026
via Kazano
Tier 3 - Non-Formulary — ✓ — ST Step therapy: 9DPP-4 INHIBITORS SECONDARY RULE- SEL DPP-4 INHIBITORS REQ PA W/O SELECT ANTI-HYPREGLYCEMIC
Something not right?